Abstract
Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic stroke and in-stent thrombosis. However, it has a number of drawbacks, including an increased risk of hemorrhage; a clinical effect that is slow in onset and irreversible; a genetically determined variability in its clinical potency; and interactions with other commonly administered drugs.
Original language | English (US) |
---|---|
Pages (from-to) | 2002-2004 |
Number of pages | 3 |
Journal | American Journal of Neuroradiology |
Volume | 32 |
Issue number | 11 |
DOIs | |
State | Published - Dec 2011 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Clinical Neurology